Investment details
Entry
Staff
42Location
NetherlandsWe are delighted that two premier Life Sciences investors, as well as our existing world-class investors, have the confidence to join and support us in the next phase of our company journey. This capital infusion will accelerate our ability to scale in the US and Europe. We will continue aggressively investing in R&D, customer success, and geographic expansion to help the medical field provide the much-needed answers for millions of people affected by sleep disorders.
Ruben de Francisco
Founder & CEO Onera Health
Partnership Gimv
This Series C financing round allows Onera Health to accelerate manufacturing and sales to meet the growing customer demand for its innovative, self-applied, no-wire end-to-end solution.
Onera Health is run by a highly skilled management team that has been able to further leverage cutting edge technology which stems from the Imec research center. We believe the company’s solution has the potential to disrupt the sleep testing market by bringing complex polysomnography studies at home, which will reduce the patient backlog in hospitals and facilitate the diagnosis of sleep diseases which incidence is steadily increasing every year.
